pI: 5.0062 |
Length (AA): 401 |
MW (Da): 42904 |
Paralog Number:
1
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
6 | 401 | 2wu9 (A) | 48 | 444 | 20.00 | 0 | 1 | 1.04343 | 0.5 |
8 | 397 | 6et9 (A) | 2 | 389 | 30.00 | 0 | 1 | 1.34597 | -0.45 |
27 | 91 | 4yuc (A) | 54 | 123 | 26.00 | 0.099 | 0.95 | 0.505495 | -0.7 |
52 | 114 | 4mz0 (B) | 173 | 232 | 40.00 | 0.99 | 0.22 | 0.451707 | 0.69 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | Dormant phase. | murphy |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Dormant phase. | hasan |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
Ortholog group members (OG5_128557)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_53275 | sterol carrier protein |
Caenorhabditis elegans | CELE_Y57A10C.6 | Protein DAF-22 |
Drosophila melanogaster | Dmel_CG17597 | CG17597 gene product from transcript CG17597-RB |
Drosophila melanogaster | Dmel_CG17320 | Sterol carrier protein X-related thiolase |
Homo sapiens | ENSG00000116171 | sterol carrier protein 2 |
Leishmania braziliensis | LbrM.23.0840 | 3-ketoacyl-CoA thiolase, putative |
Leishmania donovani | LdBPK_230860.1 | 3-ketoacyl-CoA thiolase-like protein |
Leishmania infantum | LinJ.23.0860 | 3-ketoacyl-CoA thiolase, putative |
Leishmania major | LmjF.23.0690 | 3-ketoacyl-CoA thiolase, putative |
Leishmania mexicana | LmxM.23.0690 | 3-ketoacyl-CoA thiolase-like protein |
Loa Loa (eye worm) | LOAG_16226 | hypothetical protein |
Loa Loa (eye worm) | LOAG_15893 | hypothetical protein |
Loa Loa (eye worm) | LOAG_13682 | hypothetical protein |
Loa Loa (eye worm) | LOAG_13329 | hypothetical protein |
Loa Loa (eye worm) | LOAG_12152 | hypothetical protein |
Loa Loa (eye worm) | LOAG_15100 | hypothetical protein |
Loa Loa (eye worm) | LOAG_13959 | hypothetical protein |
Loa Loa (eye worm) | LOAG_14544 | hypothetical protein |
Mus musculus | ENSMUSG00000028603 | sterol carrier protein 2, liver |
Mycobacterium tuberculosis | Rv0914c | Possible lipid carrier protein or keto acyl-CoA thiolase |
Mycobacterium tuberculosis | Rv2790c | Probable lipid-transfer protein Ltp1 |
Mycobacterium ulcerans | MUL_4955 | lipid-transfer protein Ltp1 |
Mycobacterium ulcerans | MUL_2143 | lipid-transfer protein |
Schmidtea mediterranea | mk4.002756.03 | Non-specific lipid-transfer protein-like |
Schmidtea mediterranea | mk4.003829.02 | |
Schmidtea mediterranea | mk4.005896.01 | Non-specific lipid-transfer protein |
Schmidtea mediterranea | mk4.023837.01 | Non-specific lipid-transfer protein-like |
Schmidtea mediterranea | mk4.025329.00 | Non-specific lipid-transfer protein |
Schmidtea mediterranea | mk4.078445.00 | |
Schmidtea mediterranea | mk4.049830.00 | Non-specific lipid-transfer protein-like |
Schmidtea mediterranea | mk4.016650.00 | |
Schmidtea mediterranea | mk4.007043.00 | Non-specific lipid-transfer protein |
Schmidtea mediterranea | mk4.030657.00 | Non-specific lipid-transfer protein |
Schmidtea mediterranea | mk4.003904.00 | |
Trypanosoma brucei | Tb927.8.2540 | 3-ketoacyl-CoA thiolase, putative |
Trypanosoma cruzi | TcCLB.510507.20 | 3-ketoacyl-CoA thiolase, putative |
Trypanosoma cruzi | TcCLB.509463.30 | 3-ketoacyl-CoA thiolase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu2837 this record | Mycobacterium tuberculosis | non-essential | nmpdr |
mtu930 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.8.2540 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.2540 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.2540 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.2540 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y57A10C.6 | Caenorhabditis elegans | larval arrest | wormbase |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | sterol carrier protein 2 | Compounds | References |